Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Braggio

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Blood|November 17, 2007
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibitionWee J Chng, Esteban Braggio, George Mulligan, et al.
Haematologica|May 16, 2015
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myelomaChang-Xin Shi, Klaus Martin Kortüm, Yuan Xiao Zhu, et al.
European Journal of Haematology|August 4, 2004
A systematic approach to molecular quantitative determination of mixed chimaerism following allogeneic bone marrow transplantation: an analysis of its applicability in a group of patients with severe aplastic anaemiaRocío Hassan, Martin H Bonamino, Esteban Braggio, et al.
International Journal of Hematology|December 29, 2009
Methylation status of nine tumor suppressor genes in multiple myelomaEsteban Braggio, Angelo Maiolino, Maria E Gouveia, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesVictor H Jimenez-Zepeda, Wee Joo Chng, Roelandt F J Schop, et al.
Molecular Cancer Research : MCR|June 21, 2020
Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor SensitivityChang-Xin Shi, Yuan Xiao Zhu, Laura A Bruins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Spontaneous remission in a patient with t(4;14) translocation multiple myelomaNoemi Puig, Suzanne Trudel, Jonathan J Keats, et al.
Cancer Research|May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy ResponsesTiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 26, 2018
Protocol for M<sup>3</sup>P: A Comprehensive and Clinical Oriented Targeted Sequencing Panel for Routine Molecular Analysis in Multiple MyelomaSantiago Barrio, Matteo DáVia, Laura Bruins, et al.
Blood Advances|May 14, 2025
Extramedullary Myeloma is Genomically Complex and Characterized by Near-Universal MAPK Pathway AlterationsSaurabh Zanwar, Joseph Novak, Wilson I Gonsalves, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Blood|November 17, 2007
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibitionWee J Chng, Esteban Braggio, George Mulligan, et al.
Haematologica|May 16, 2015
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myelomaChang-Xin Shi, Klaus Martin Kortüm, Yuan Xiao Zhu, et al.
European Journal of Haematology|August 4, 2004
A systematic approach to molecular quantitative determination of mixed chimaerism following allogeneic bone marrow transplantation: an analysis of its applicability in a group of patients with severe aplastic anaemiaRocío Hassan, Martin H Bonamino, Esteban Braggio, et al.
International Journal of Hematology|December 29, 2009
Methylation status of nine tumor suppressor genes in multiple myelomaEsteban Braggio, Angelo Maiolino, Maria E Gouveia, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesVictor H Jimenez-Zepeda, Wee Joo Chng, Roelandt F J Schop, et al.
Molecular Cancer Research : MCR|June 21, 2020
Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor SensitivityChang-Xin Shi, Yuan Xiao Zhu, Laura A Bruins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Spontaneous remission in a patient with t(4;14) translocation multiple myelomaNoemi Puig, Suzanne Trudel, Jonathan J Keats, et al.
Cancer Research|May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy ResponsesTiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 26, 2018
Protocol for M<sup>3</sup>P: A Comprehensive and Clinical Oriented Targeted Sequencing Panel for Routine Molecular Analysis in Multiple MyelomaSantiago Barrio, Matteo DáVia, Laura Bruins, et al.
Blood Advances|May 14, 2025
Extramedullary Myeloma is Genomically Complex and Characterized by Near-Universal MAPK Pathway AlterationsSaurabh Zanwar, Joseph Novak, Wilson I Gonsalves, et al.
Pageof 15